These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1693846)

  • 1. In vitro isolation of a neutralization escape mutant of equine infectious anemia virus (EIAV).
    Rwambo PM; Issel CJ; Hussain KA; Montelaro RC
    Arch Virol; 1990; 111(3-4):275-80. PubMed ID: 1693846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype.
    Howe L; Leroux C; Issel CJ; Montelaro RC
    J Virol; 2002 Nov; 76(21):10588-97. PubMed ID: 12368301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies.
    Hussain KA; Issel CJ; Schnorr KL; Rwambo PM; Montelaro RC
    J Virol; 1987 Oct; 61(10):2956-61. PubMed ID: 2442410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic mapping of the envelope proteins of equine infectious anemia virus: identification of a neutralization domain and a conserved region on glycoprotein 90.
    Hussain KA; Issel CJ; Schnorr KL; Rwambo PM; West M; Montelaro RC
    Arch Virol; 1988; 98(3-4):213-24. PubMed ID: 2450529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection.
    Salinovich O; Payne SL; Montelaro RC; Hussain KA; Issel CJ; Schnorr KL
    J Virol; 1986 Jan; 57(1):71-80. PubMed ID: 3001367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equine infectious anemia virus (EIAV) humoral responses of recipient ponies and antigenic variation during persistent infection.
    Rwambo PM; Issel CJ; Adams WV; Hussain KA; Miller M; Montelaro RC
    Arch Virol; 1990; 111(3-4):199-212. PubMed ID: 2162160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of conserved and variable antigenic domains of equine infectious anemia virus envelope glycoproteins using recombinant env-encoded protein fragments produced in Escherichia coli.
    Payne SL; Rushlow K; Dhruva BR; Issel CJ; Montelaro RC
    Virology; 1989 Oct; 172(2):609-15. PubMed ID: 2552661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced sensitivity to neutralizing antibodies in a variant of equine infectious anemia virus is linked to amino acid substitutions in the surface unit envelope glycoprotein.
    Cook RF; Berger SL; Rushlow KE; McManus JM; Cook SJ; Harrold S; Raabe ML; Montelaro RC; Issel CJ
    J Virol; 1995 Mar; 69(3):1493-9. PubMed ID: 7853482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of serum neutralizing antibodies induced by transient immune suppression of inapparent carrier ponies infected with a neutralization-resistant equine infectious anemia virus envelope strain.
    Howe L; Craigo JK; Issel CJ; Montelaro RC
    J Gen Virol; 2005 Jan; 86(Pt 1):139-149. PubMed ID: 15604441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the escape mutants of rabies virus which are resistant to neutralization by a highly conserved conformational epitope-specific monoclonal antibody #1-46-12.
    Irie T; Matsuda Y; Honda Y; Morimoto K; Kawai A
    Microbiol Immunol; 2002; 46(7):449-61. PubMed ID: 12222931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino acid mutations in the env gp90 protein that modify N-linked glycosylation of the Chinese EIAV vaccine strain enhance resistance to neutralizing antibodies.
    Han X; Zou J; Wang X; Guo W; Huo G; Shen R; Xiang W
    Viral Immunol; 2010 Oct; 23(5):531-9. PubMed ID: 20883167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient immune suppression of inapparent carriers infected with a principal neutralizing domain-deficient equine infectious anaemia virus induces neutralizing antibodies and lowers steady-state virus replication.
    Craigo JK; Leroux C; Howe L; Steckbeck JD; Cook SJ; Issel CJ; Montelaro RC
    J Gen Virol; 2002 Jun; 83(Pt 6):1353-1359. PubMed ID: 12029150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony.
    Leroux C; Issel CJ; Montelaro RC
    J Virol; 1997 Dec; 71(12):9627-39. PubMed ID: 9371627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and characterization of an equine infectious anemia virus Env-pseudotyped reporter virus.
    Tallmadge RL; Brindley MA; Salmans J; Mealey RH; Maury W; Carpenter S
    Clin Vaccine Immunol; 2008 Jul; 15(7):1138-40. PubMed ID: 18448619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus.
    Montelaro RC; Parekh B; Orrego A; Issel CJ
    J Biol Chem; 1984 Aug; 259(16):10539-44. PubMed ID: 6206055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus.
    Hammond SA; Raabe ML; Issel CJ; Montelaro RC
    Virology; 1999 Sep; 262(2):416-30. PubMed ID: 10502520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of epitopes on the rabies virus glycoprotein by selection and analysis of escape mutants.
    Fallahi F; Wandeler AI; Nadin-Davis SA
    Virus Res; 2016 Jul; 220():161-71. PubMed ID: 27132040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of equine arteritis virus isolates using neutralizing monoclonal antibodies and identification of sequence changes in GL associated with neutralization resistance.
    Glaser AL; de Vries AA; Dubovi EJ
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2223-33. PubMed ID: 7561759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detailed mapping of the antigenicity of the surface unit glycoprotein of equine infectious anemia virus by using synthetic peptide strategies.
    Ball JM; Rushlow KE; Issel CJ; Montelaro RC
    J Virol; 1992 Feb; 66(2):732-42. PubMed ID: 1370556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of equine infectious anemia virus to the equine lentivirus receptor-1 is mediated by complex discontinuous sequences in the viral envelope gp90 protein.
    Sun C; Zhang B; Jin J; Montelaro RC
    J Gen Virol; 2008 Aug; 89(Pt 8):2011-2019. PubMed ID: 18632973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.